AnalystBook Research · Company Intelligence

Bold Eagle Acquisition Corp.

BEAGNasdaq

Built from Bold Eagle Acquisition Corp.'s own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

Bold Eagle is a SPAC with stronger net income, weaker cash from ops, and an October 2026 completion window.

The read at a glance✓ Audited against SEC data
  • Business mixBlank check companyNote
  • RevenueNo revenue in bundle financialsNote
  • ProfitabilityNet income rose to $9.8MOK
  • CashCash from ops weakenedWatch
  • EquityEquity stayed near -$7.9MNote
  • Insiders0 purchases / 0 salesNote
  • AccountingNo current forensic screen in bundleNote

Business

Bold Eagle Acquisition is a Cayman Islands blank check company seeking a business combination, with management highlighting special situations such as consolidations, carve-outs, and global companies seeking U.S. market access.

Leadership changes

From Bold Eagle Acquisition Corp.'s own filings, the day they're filed.

  • Diarmuid Cummins · directors · appointmenteff. 2024-10-23
  • Amy Gershkoff Bolles · directors · appointmenteff. 2024-10-23
  • Jason Park · directors · appointmenteff. 2024-10-23

Latest filings

  • 10-Q · Quarterly report2026-08-14
  • 10-Q · Quarterly report2026-05-15
  • 10-K · Annual report2026-03-23
  • 10-Q · Quarterly report2025-11-13
  • 10-Q · Quarterly report2025-08-14
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • Main tension🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about Bold Eagle Acquisition Corp., every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.